US Bacterial Cell Culture Market

ID: MRFR/LS/17758-HCR
100 Pages
Rahul Gotadki
Last Updated: May 13, 2026
US Bacterial Cell Culture Market Research Report By Product (Consumables, Equipment, others), By Application (Biopharmaceutical, Cytogenetic, Food Testing, Water Testing, others) and By End User (Hospitals and Diagnostic Centers, Academic and Research Laboratories, Biopharmaceutical Companies, others) - Growth & Industry Forecast 2025 To 2035
US Bacterial Cell Culture Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.66%
2024 Market Size$ 540.98 Million
2025 Market Size$ 577.01 Million
2035 Market Size$ 1,100 Million
Key Players
Thermo Fisher Scientific
Merck KGaA
Becton Dickinson and Company
Lonza Group
Corning Incorporated
GE Healthcare
Trends
  • Technological Advancements
  • Rising Demand for Biologics
  • Focus on Quality Control
Opportunities
  • Increased Research Funding
  • Emerging Regulatory Frameworks
  • Rising Focus on Synthetic Biology
Summary Table of Contents Segmentation Download PDF
  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
    1. 1.1 EXECUTIVE SUMMARY | |
      1. 1.1.1 Market Overview | |
      2. 1.1.2 Key Findings | |
      3. 1.1.3 Market Segmentation | |
      4. 1.1.4 Competitive Landscape | |
      5. 1.1.5 Challenges and Opportunities | |
      6. 1.1.6 Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
    1. 2.1 MARKET INTRODUCTION | |
      1. 2.1.1 Definition | |
      2. 2.1.2 Scope of the study | | |
        1. 2.1.2.1 Research Objective | | |
        2. 2.1.2.2 Assumption | | |
        3. 2.1.2.3 Limitations |
    2. 2.2 RESEARCH METHODOLOGY | |
      1. 2.2.1 Overview | |
      2. 2.2.2 Data Mining | |
      3. 2.2.3 Secondary Research | |
      4. 2.2.4 Primary Research | | |
        1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
        2. 2.2.4.2 Breakdown of Primary Respondents | |
      5. 2.2.5 Forecasting Model | |
      6. 2.2.6 Market Size Estimation | | |
        1. 2.2.6.1 Bottom-Up Approach | | |
        2. 2.2.6.2 Top-Down Approach | |
      7. 2.2.7 Data Triangulation | |
      8. 2.2.8 Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS |
    1. 3.1 MARKET DYNAMICS | |
      1. 3.1.1 Overview | |
      2. 3.1.2 Drivers | |
      3. 3.1.3 Restraints | |
      4. 3.1.4 Opportunities |
    2. 3.2 MARKET FACTOR ANALYSIS | |
      1. 3.2.1 Value chain Analysis | |
      2. 3.2.2 Porter's Five Forces Analysis | | |
        1. 3.2.2.1 Bargaining Power of Suppliers | | |
        2. 3.2.2.2 Bargaining Power of Buyers | | |
        3. 3.2.2.3 Threat of New Entrants | | |
        4. 3.2.2.4 Threat of Substitutes | | |
        5. 3.2.2.5 Intensity of Rivalry | |
      3. 3.2.3 COVID-19 Impact Analysis | | |
        1. 3.2.3.1 Market Impact Analysis | | |
        2. 3.2.3.2 Regional Impact | | |
        3. 3.2.3.3 Opportunity and Threat Analysis 4
  4. SECTION IV: QUANTITATIVE ANALYSIS |
    1. 4.1 Construction, BY Product (USD Million) | |
      1. 4.1.1 Equipment | |
      2. 4.1.2 Consumables |
    2. 4.2 Construction, BY Application (USD Million) | |
      1. 4.2.1 Biopharmaceutical | |
      2. 4.2.2 Cytogenetic | |
      3. 4.2.3 Food Testing | |
      4. 4.2.4 Water Testing | |
      5. 4.2.5 Others |
    3. 4.3 Construction, BY Targeted Audience (USD Million) | |
      1. 4.3.1 Cell culture media manufacturing companies | |
      2. 4.3.2 Healthcare organizations | |
      3. 4.3.3 Healthcare providers | |
      4. 4.3.4 Government organizations | |
      5. 4.3.5 Contract manufacturing organization (CMO) | |
      6. 4.3.6 Research and development (R&D) companies |
    4. 4.4 Construction, BY End-User (USD Million) | |
      1. 4.4.1 Hospitals and Diagnostic Centers | |
      2. 4.4.2 Academic and Research Laboratories | |
      3. 4.4.3 Biopharmaceutical Companies | |
      4. 4.4.4 Others 5
  5. SECTION V: COMPETITIVE ANALYSIS |
    1. 5.1 Competitive Landscape | |
      1. 5.1.1 Overview | |
      2. 5.1.2 Competitive Analysis | |
      3. 5.1.3 Market share Analysis | |
      4. 5.1.4 Major Growth Strategy in the Construction | |
      5. 5.1.5 Competitive Benchmarking | |
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Construction | |
      7. 5.1.7 Key developments and growth strategies | | |
        1. 5.1.7.1 New Product Launch/Service Deployment | | |
        2. 5.1.7.2 Merger & Acquisitions | | |
        3. 5.1.7.3 Joint Ventures | |
      8. 5.1.8 Major Players Financial Matrix | | |
        1. 5.1.8.1 Sales and Operating Income | | |
        2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
    2. 5.2 Company Profiles | |
      1. 5.2.1 Thermo Fisher Scientific (US) | | |
        1. 5.2.1.1 Financial Overview | | |
        2. 5.2.1.2 Products Offered | | |
        3. 5.2.1.3 Key Developments | | |
        4. 5.2.1.4 SWOT Analysis | | |
        5. 5.2.1.5 Key Strategies | |
      2. 5.2.2 Merck KGaA (DE) | | |
        1. 5.2.2.1 Financial Overview | | |
        2. 5.2.2.2 Products Offered | | |
        3. 5.2.2.3 Key Developments | | |
        4. 5.2.2.4 SWOT Analysis | | |
        5. 5.2.2.5 Key Strategies | |
      3. 5.2.3 Becton Dickinson and Company (US) | | |
        1. 5.2.3.1 Financial Overview | | |
        2. 5.2.3.2 Products Offered | | |
        3. 5.2.3.3 Key Developments | | |
        4. 5.2.3.4 SWOT Analysis | | |
        5. 5.2.3.5 Key Strategies | |
      4. 5.2.4 Lonza Group (CH) | | |
        1. 5.2.4.1 Financial Overview | | |
        2. 5.2.4.2 Products Offered | | |
        3. 5.2.4.3 Key Developments | | |
        4. 5.2.4.4 SWOT Analysis | | |
        5. 5.2.4.5 Key Strategies | |
      5. 5.2.5 Corning Incorporated (US) | | |
        1. 5.2.5.1 Financial Overview | | |
        2. 5.2.5.2 Products Offered | | |
        3. 5.2.5.3 Key Developments | | |
        4. 5.2.5.4 SWOT Analysis | | |
        5. 5.2.5.5 Key Strategies | |
      6. 5.2.6 GE Healthcare (GB) | | |
        1. 5.2.6.1 Financial Overview | | |
        2. 5.2.6.2 Products Offered | | |
        3. 5.2.6.3 Key Developments | | |
        4. 5.2.6.4 SWOT Analysis | | |
        5. 5.2.6.5 Key Strategies | |
      7. 5.2.7 Sigma-Aldrich (US) | | |
        1. 5.2.7.1 Financial Overview | | |
        2. 5.2.7.2 Products Offered | | |
        3. 5.2.7.3 Key Developments | | |
        4. 5.2.7.4 SWOT Analysis | | |
        5. 5.2.7.5 Key Strategies | |
      8. 5.2.8 F. Hoffmann-La Roche Ltd (CH) | | |
        1. 5.2.8.1 Financial Overview | | |
        2. 5.2.8.2 Products Offered | | |
        3. 5.2.8.3 Key Developments | | |
        4. 5.2.8.4 SWOT Analysis | | |
        5. 5.2.8.5 Key Strategies |
    3. 5.3 Appendix | |
      1. 5.3.1 References | |
      2. 5.3.2 Related Reports 6 LIST OF FIGURES |
    4. 6.1 MARKET SYNOPSIS |
    5. 6.2 US MARKET ANALYSIS BY PRODUCT |
    6. 6.3 US MARKET ANALYSIS BY APPLICATION |
    7. 6.4 US MARKET ANALYSIS BY TARGETED AUDIENCE |
    8. 6.5 US MARKET ANALYSIS BY END-USER |
    9. 6.6 KEY BUYING CRITERIA OF CONSTRUCTION |
    10. 6.7 RESEARCH PROCESS OF MRFR |
    11. 6.8 DRO ANALYSIS OF CONSTRUCTION |
    12. 6.9 DRIVERS IMPACT ANALYSIS: CONSTRUCTION |
    13. 6.10 RESTRAINTS IMPACT ANALYSIS: CONSTRUCTION |
    14. 6.11 SUPPLY / VALUE CHAIN: CONSTRUCTION |
    15. 6.12 CONSTRUCTION, BY PRODUCT, 2024 (% SHARE) |
    16. 6.13 CONSTRUCTION, BY PRODUCT, 2024 TO 2035 (USD Million) |
    17. 6.14 CONSTRUCTION, BY APPLICATION, 2024 (% SHARE) |
    18. 6.15 CONSTRUCTION, BY APPLICATION, 2024 TO 2035 (USD Million) |
    19. 6.16 CONSTRUCTION, BY TARGETED AUDIENCE, 2024 (% SHARE) |
    20. 6.17 CONSTRUCTION, BY TARGETED AUDIENCE, 2024 TO 2035 (USD Million) |
    21. 6.18 CONSTRUCTION, BY END-USER, 2024 (% SHARE) |
    22. 6.19 CONSTRUCTION, BY END-USER, 2024 TO 2035 (USD Million) |
    23. 6.20 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
    24. 7.1 LIST OF ASSUMPTIONS | |
      1. 7.1.1 |
    25. 7.2 US MARKET SIZE ESTIMATES; FORECAST | |
      1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million) | |
      2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million) | |
      3. 7.2.3 BY TARGETED AUDIENCE, 2025-2035 (USD Million) | |
      4. 7.2.4 BY END-USER, 2025-2035 (USD Million) |
    26. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
      1. 7.3.1 |
    27. 7.4 ACQUISITION/PARTNERSHIP | |

US Bacterial Cell Culture Market Segmentation

US Bacterial Cell Culture Market By Product (USD Million, 2025-2035)

  • Equipment
  • Consumables

US Bacterial Cell Culture Market By Application (USD Million, 2025-2035)

  • Biopharmaceutical
  • Cytogenetic
  • Food Testing
  • Water Testing
  • Others

US Bacterial Cell Culture Market By Targeted Audience (USD Million, 2025-2035)

  • Cell culture media manufacturing companies
  • US Bacterial Cell Culture Market organizations
  • US Bacterial Cell Culture Market providers
  • Government organizations
  • Contract manufacturing organization (CMO)
  • Research and development (R&D) companies

US Bacterial Cell Culture Market By End-User (USD Million, 2025-2035)

  • Hospitals and Diagnostic Centers
  • Academic and Research Laboratories
  • Biopharmaceutical Companies
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.